217 related articles for article (PubMed ID: 23246743)
21. GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.
Li NX; Brown S; Kowalski T; Wu M; Yang L; Dai G; Petrov A; Ding Y; Dlugos T; Wood HB; Wang L; Erion M; Sherwin R; Kelley DE
Diabetes; 2018 Jul; 67(7):1401-1413. PubMed ID: 29669745
[TBL] [Abstract][Full Text] [Related]
22. Compound K enhances insulin secretion with beneficial metabolic effects in db/db mice.
Han GC; Ko SK; Sung JH; Chung SH
J Agric Food Chem; 2007 Dec; 55(26):10641-8. PubMed ID: 18034458
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic potential of GPR119 agonists for type 2 diabetes.
Ohishi T; Yoshida S
Expert Opin Investig Drugs; 2012 Mar; 21(3):321-8. PubMed ID: 22292451
[TBL] [Abstract][Full Text] [Related]
24. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
[TBL] [Abstract][Full Text] [Related]
25. Yhhu4488, a novel GPR40 agonist, promotes GLP-1 secretion and exerts anti-diabetic effect in rodent models.
Guo DY; Li DW; Ning MM; Dang XY; Zhang LN; Zeng LM; Hu YH; Leng Y
Biochem Biophys Res Commun; 2015 Oct; 466(4):740-7. PubMed ID: 26417688
[TBL] [Abstract][Full Text] [Related]
26. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.
Soga T; Ohishi T; Matsui T; Saito T; Matsumoto M; Takasaki J; Matsumoto S; Kamohara M; Hiyama H; Yoshida S; Momose K; Ueda Y; Matsushime H; Kobori M; Furuichi K
Biochem Biophys Res Commun; 2005 Jan; 326(4):744-51. PubMed ID: 15607732
[TBL] [Abstract][Full Text] [Related]
27. Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.
Negoro K; Yonetoku Y; Misawa-Mukai H; Hamaguchi W; Maruyama T; Yoshida S; Takeuchi M; Ohta M
Bioorg Med Chem; 2012 Sep; 20(17):5235-46. PubMed ID: 22836190
[TBL] [Abstract][Full Text] [Related]
28. 2-OMe-lysophosphatidylcholine analogues are GPR119 ligands and activate insulin secretion from βTC-3 pancreatic cells: Evaluation of structure-dependent biological activity.
Drzazga A; Sowińska A; Krzemińska A; Okruszek A; Paneth P; Koziołkiewicz M; Gendaszewska-Darmach E
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jan; 1863(1):91-103. PubMed ID: 29079451
[TBL] [Abstract][Full Text] [Related]
29. 5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion.
Kogure R; Toyama K; Hiyamuta S; Kojima I; Takeda S
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):58-63. PubMed ID: 22079287
[TBL] [Abstract][Full Text] [Related]
30. Hypoglycemic effect of aspalathin, a rooibos tea component from Aspalathus linearis, in type 2 diabetic model db/db mice.
Kawano A; Nakamura H; Hata S; Minakawa M; Miura Y; Yagasaki K
Phytomedicine; 2009 May; 16(5):437-43. PubMed ID: 19188054
[TBL] [Abstract][Full Text] [Related]
31. The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection.
Lei L; Liu S; Li Y; Song H; He L; Liu Q; Sun S; Li Y; Feng Z; Shen Z
Eur J Pharmacol; 2018 May; 826():17-23. PubMed ID: 29477658
[TBL] [Abstract][Full Text] [Related]
32. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
33. In vivo efficacy of HD0471953: a novel GPR119 agonist for the treatment of type 2 diabetes mellitus.
Kim SR; Kim DH; Park SH; Kim YS; Kim CH; Ha TY; Yang J; Rhee JK
J Diabetes Res; 2013; 2013():269569. PubMed ID: 24386644
[TBL] [Abstract][Full Text] [Related]
34. DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.
Sun P; Wang T; Zhou Y; Liu H; Jiang H; Zhu W; Wang H
PLoS One; 2013; 8(6):e66744. PubMed ID: 23776696
[TBL] [Abstract][Full Text] [Related]
35. Serotonin receptor 2C and insulin secretion.
Zhang Q; Zhu Y; Zhou W; Gao L; Yuan L; Han X
PLoS One; 2013; 8(1):e54250. PubMed ID: 23349838
[TBL] [Abstract][Full Text] [Related]
36. HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies.
Kim S; Kim DH; Kim YS; Ha TY; Yang J; Park SH; Jeong KW; Rhee JK
Biomol Ther (Seoul); 2014 Sep; 22(5):400-5. PubMed ID: 25414769
[TBL] [Abstract][Full Text] [Related]
37. Asparagus officinalis extract controls blood glucose by improving insulin secretion and β-cell function in streptozotocin-induced type 2 diabetic rats.
Hafizur RM; Kabir N; Chishti S
Br J Nutr; 2012 Nov; 108(9):1586-95. PubMed ID: 22221560
[TBL] [Abstract][Full Text] [Related]
38. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation.
Ma X; Hui H; Liu Z; He G; Hu J; Meng J; Guan L; Luo X
Diabetes Obes Metab; 2009 Oct; 11(10):953-65. PubMed ID: 19531053
[TBL] [Abstract][Full Text] [Related]
39. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
[TBL] [Abstract][Full Text] [Related]
40. Stimulating β-cell replication and improving islet graft function by AR231453, A GPR119 agonist.
Gao J; Tian L; Weng G; O'Brien TD; Luo J; Guo Z
Transplant Proc; 2011 Nov; 43(9):3217-20. PubMed ID: 22099761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
